Beyond COVID-19 Spending Growth, Biosimilars Slowed Growth In Other Categories
IQVIA Finds Non-COVID Drug Spending Up Just 5%
The COVID-19 windfall meant a 12% rise in spending on medicines in the US in 2021 versus 2020, but just 5% excluding COVID, which is expected to fall to 1%-4% compound annual growth through 2026.
